FCM
Frontier Capital Management Portfolio holdings
AUM
$10.8B
1-Year Return
32.36%
This Quarter Return
+4.75%
1 Year Return
+32.36%
3 Year Return
+147.77%
5 Year Return
+285.35%
10 Year Return
+891.74%
AUM
$12.2B
AUM Growth
-$389M
(-3.1%)
Cap. Flow
-$570M
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
12.87%
Holding
355
New
13
Increased
118
Reduced
193
Closed
16
Top Buys
| 1 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$44M |
| 2 |
Universal Display
OLED
|
$43.5M |
| 3 |
Martin Marietta Materials
MLM
|
$39.9M |
| 4 |
A.O. Smith
AOS
|
$34.6M |
| 5 |
Align Technology
ALGN
|
$31.3M |
Top Sells
| 1 |
American Airlines Group
AAL
|
$72M |
| 2 |
QLGC
QLOGIC CORP
QLGC
|
$54.3M |
| 3 |
Perrigo
PRGO
|
$45.4M |
| 4 |
Dollar Tree
DLTR
|
$44.4M |
| 5 |
Bath & Body Works
BBWI
|
$41.7M |
Sector Composition
| 1 | Technology | 21.43% |
| 2 | Industrials | 19.83% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMSG
276
DELISTED
Amsurg Corp
AMSG
| $3.51M | 0.03% |
45,206
-8,870
| -16% | -$688K |
|
277
Pacira BioSciences
PCRX
$1.19B
| $3.45M | 0.03% |
102,244
-63,218
| -38% | -$2.13M |
|
|
ITCI
278
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.18M | 0.03% |
81,999
-111,615
| -58% | -$4.33M |
|
279
Sangamo Therapeutics
SGMO
$165M
| $2.98M | 0.02% |
513,930
-313,637
| -38% | -$1.82M |
|
|
BLUE
280
DELISTED
bluebird bio
BLUE
| $2.65M | 0.02% |
4,717
-2,439
| -34% | -$1.37M |
|
|
CFMS
281
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.61M | 0.02% |
+14,858
| New | +$2.61M |
|
282
Precigen
PGEN
$1.3B
| $2.24M | 0.02% |
91,617
-404,996
| -82% | -$9.88M |
|
283
Broadcom
AVGO
$1.58T
| $1.96M | 0.02% |
125,780
-12,180
| -9% | -$189K |
|
284
UnitedHealth
UNH
$286B
| $1.7M | 0.01% |
12,045
-1,161
| -9% | -$164K |
|
|
MDCO
285
DELISTED
Medicines Co
MDCO
| $1.7M | 0.01% |
50,529
-9,895
| -16% | -$333K |
|
286
Alphabet (Google) Class C
GOOG
$2.84T
| $1.44M | 0.01% |
41,660
-3,900
| -9% | -$135K |
|
287
Cognizant
CTSH
$35.1B
| $1.36M | 0.01% |
23,777
-2,284
| -9% | -$131K |
|
288
Bristol-Myers Squibb
BMY
$96B
| $1.28M | 0.01% |
17,402
-1,669
| -9% | -$123K |
|
289
TJX Companies
TJX
$155B
| $1.27M | 0.01% |
32,800
-7,576
| -19% | -$293K |
|
290
Apple
AAPL
$3.56T
| $1.15M | 0.01% |
48,056
-11,480
| -19% | -$274K |
|
291
Blackrock
BLK
$170B
| $1.12M | 0.01% |
3,274
-322
| -9% | -$110K |
|
|
AGN
292
DELISTED
Allergan plc
AGN
| $992K | 0.01% |
4,292
-415
| -9% | -$95.9K |
|
293
Oracle
ORCL
$654B
| $932K | 0.01% |
22,774
-2,199
| -9% | -$90K |
|
294
American International
AIG
$43.9B
| $896K | 0.01% |
16,932
-1,622
| -9% | -$85.8K |
|
295
JPMorgan Chase
JPM
$809B
| $896K | 0.01% |
14,426
-1,381
| -9% | -$85.8K |
|
296
Biogen
BIIB
$20.6B
| $833K | 0.01% |
3,446
-331
| -9% | -$80K |
|
|
GWR
297
DELISTED
Genesee & Wyoming Inc.
GWR
| $683K | 0.01% |
11,591
-1,117
| -9% | -$65.8K |
|
298
Teva Pharmaceuticals
TEVA
$21.7B
| $612K | 0.01% |
12,186
-1,167
| -9% | -$58.6K |
|
|
GNC
299
DELISTED
GNC Holdings, Inc.
GNC
| $538K | ﹤0.01% |
22,148
+686
| +3% | +$16.7K |
|
|
300
Perrigo
PRGO
$3.12B
| $298K | ﹤0.01% |
4,679
-713,477
| -99% | -$45.4M |
|